T. Rowe Price Associates’s SpringWorks Therapeutics SWTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.26M | Sell |
69,269
-2,513,463
| -97% | -$118M | ﹤0.01% | 1440 |
|
|
2025
Q1 | $114M | Sell |
2,582,732
-692,054
| -21% | -$30.5M | 0.01% | 533 |
|
|
2024
Q4 | $118M | Sell |
3,274,786
-241,632
| -7% | -$8.73M | 0.01% | 536 |
|
|
2024
Q3 | $113M | Sell |
3,516,418
-85,816
| -2% | -$2.75M | 0.01% | 541 |
|
|
2024
Q2 | $136M | Sell |
3,602,234
-508,228
| -12% | -$19.1M | 0.02% | 478 |
|
|
2024
Q1 | $202M | Buy |
4,110,462
+1,333,892
| +48% | +$65.7M | 0.02% | 418 |
|
|
2023
Q4 | $101M | Buy |
2,776,570
+1,221,056
| +78% | +$44.6M | 0.01% | 538 |
|
|
2023
Q3 | $36M | Buy |
1,555,514
+214,884
| +16% | +$4.97M | 0.01% | 773 |
|
|
2023
Q2 | $35.2M | Buy |
1,340,630
+1,067,203
| +390% | +$28M | ﹤0.01% | 801 |
|
|
2023
Q1 | $7.04M | Buy |
273,427
+34,774
| +15% | +$895K | ﹤0.01% | 1112 |
|
|
2022
Q4 | $6.21M | Sell |
238,653
-10,202
| -4% | -$265K | ﹤0.01% | 1141 |
|
|
2022
Q3 | $7.1M | Buy |
248,855
+7,412
| +3% | +$211K | ﹤0.01% | 1131 |
|
|
2022
Q2 | $5.94M | Sell |
241,443
-73,999
| -23% | -$1.82M | ﹤0.01% | 1397 |
|
|
2022
Q1 | $17.8M | Buy |
315,442
+3,401
| +1% | +$192K | ﹤0.01% | 1257 |
|
|
2021
Q4 | $19.3M | Buy |
312,041
+4,634
| +2% | +$287K | ﹤0.01% | 1290 |
|
|
2021
Q3 | $19.5M | Sell |
307,407
-1,530
| -0.5% | -$97.1K | ﹤0.01% | 1302 |
|
|
2021
Q2 | $25.5M | Sell |
308,937
-18,742
| -6% | -$1.54M | ﹤0.01% | 1236 |
|
|
2021
Q1 | $24.1M | Buy |
327,679
+1,499
| +0.5% | +$110K | ﹤0.01% | 1229 |
|
|
2020
Q4 | $23.7M | Buy |
+326,180
| New | +$23.7M | ﹤0.01% | 1178 |
|